Powder: -20°C for 3 years | In solvent: -80°C for 1 year
VU0422288 (ML396) 是一种有效的 III 型 mGlu 受体 (mGlus) 正变构调节剂。VU0422288在钙动员试验中对 mGluR4、mGluR7 和 mGluR8 显示出抑制作用。VU0422288 可用于研究 Rett 综合症 (RTT)。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 745 | 现货 | ||
10 mg | ¥ 1,230 | 现货 | ||
25 mg | ¥ 2,370 | 现货 | ||
50 mg | ¥ 3,530 | 现货 | ||
100 mg | ¥ 4,970 | 现货 | ||
500 mg | ¥ 10,700 | 现货 |
产品描述 | VU0422288 (ML396) is a potent orthosteric modulator of type III mGlu receptors (mGlus).VU0422288 shows inhibition of mGluR4, mGluR7, and mGluR8 in a calcium mobilization assay.VU0422288 can be used to study Rett syndrome (RTT). |
靶点活性 | mGluR4:108 nM (EC50), mGluR7:146 nM (EC50), mGluR8:128 nM (EC50) |
体外活性 | In coronal slices containing the hippocampus, VU0422288 (1 μM; 5 minutes) enhances the reduction in slope of the field excitatory postsynaptic potentials (fEPSPs) induced by 30 μM LSP4-2022[1].However, when administered alone for 10 minutes at a concentration of 1 μM, VU0422288 does not alter the slope of fEPSP, indicating that under stimulation conditions, mGlu7 does not possess reinforcing activity in Mecp2-/y slices[1]. |
体内活性 |
In Mecp2+/- mice, VU0422288 (30 mg/kg; intraperitoneal injection; once daily for 17 days) rescues synaptic plasticity deficits and learning-memory phenotypes, reduces the frequency of respiratory pause, while showing no effect in Mecp2+/+ animals[1]. A single dose of VU0422288 (10 mg/kg; intraperitoneal injection) in adult male Sprague-Dawley rats exhibits a plasma/brain partition coefficient of 1.67, predicting a free brain concentration of approximately 40 nM[1]. |
别名 | VU-0422288, ML-396, ML396, VU 0422288, ML 396 |
分子量 | 360.19 |
分子式 | C17H11Cl2N3O2 |
CAS No. | 1630936-95-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL(55.53 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.7763 mL | 13.8816 mL | 27.7631 mL | 69.4078 mL |
5 mM | 0.5553 mL | 2.7763 mL | 5.5526 mL | 13.8816 mL | |
10 mM | 0.2776 mL | 1.3882 mL | 2.7763 mL | 6.9408 mL | |
20 mM | 0.1388 mL | 0.6941 mL | 1.3882 mL | 3.4704 mL | |
50 mM | 0.0555 mL | 0.2776 mL | 0.5553 mL | 1.3882 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
VU0422288 1630936-95-6 Neuroscience GluR VU-0422288 ML-396 ML396 VU 0422288 ML 396 Inhibitor inhibitor inhibit